ELMSAN1 Antibody [mFluor Violet 610 SE]

• Reactivity: Hu
• Applications: WB, IP, Mycoplasma
• Clonality: Polyclonal
• Host: Rabbit
• Conjugate: mFluor Violet 610 SE

ELMSAN1 Antibody [mFluor Violet 610 SE] Summary

• Immunogen: The immunogen for this product maps to a region between residue 550 and 600 of human ELMSAN1 Open Reading Frame 43 using the numbering given in entry NP_001036783.1 (GeneID 91748).
• Isotype: IgG
• Clonality: Polyclonal
• Host: Rabbit
• Gene: ELMSAN1
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • Immunoprecipitation
  • Knockdown Validated
  • Western Blot
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Immunogen affinity purified

Notes

mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.

Alternate Names for ELMSAN1 Antibody [mFluor Violet 610 SE]

• c14_5541
• C14orf117
• C14orf43
• chromosome 14 open reading frame 117
• chromosome 14 open reading frame 43
• ELM2 and Myb/SANT-like domain containing 1
• ELMSAN1
• FLJ00335
• hypothetical protein LOC91748
• LSR68

Background

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene. The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo. Chimera RNAi has many advantages over the conventional siRNAs. First, it has been demonstrated to have reliable knock-down for over 10,000 human genes. Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence. Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected. Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: ELMSAN1